{"organizations": [], "uuid": "79af26dd26a2585bb08e3734ee639370c34f6287", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-advanced-accelerator-applications/brief-advanced-accelerator-applications-enters-into-worldwide-license-agreement-with-cancer-targeted-technology-idUSFWN1Q20SK", "country": "US", "domain_rank": 408, "title": "BRIEF-Advanced Accelerator Applications Enters Into Worldwide License Agreement With Cancer Targeted Technology", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-12T14:08:00.000+02:00", "replies_count": 0, "uuid": "79af26dd26a2585bb08e3734ee639370c34f6287"}, "author": "", "url": "https://www.reuters.com/article/brief-advanced-accelerator-applications/brief-advanced-accelerator-applications-enters-into-worldwide-license-agreement-with-cancer-targeted-technology-idUSFWN1Q20SK", "ord_in_thread": 0, "title": "BRIEF-Advanced Accelerator Applications Enters Into Worldwide License Agreement With Cancer Targeted Technology", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "cancer targeted technology reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 12, 2018 / 12:11 PM / in 10 minutes BRIEF-Advanced Accelerator Applications Enters Into Worldwide License Agreement With Cancer Targeted Technology Reuters Staff \nFeb 12 (Reuters) - Advanced Accelerator Applications SA : \n* ADVANCED ACCELERATOR APPLICATIONS SA - ENTERED INTO EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH CANCER TARGETED TECHNOLOGY \n* ADVANCED ACCELERATOR APPLICATIONS SA - AGREEMENT WITH CTT TO DEVELOP AND MARKET INVESTIGATIONAL NEW DRUG PRODUCT, F-18-LABELED CTT1057 \n* ADVANCED ACCELERATOR APPLICATIONS SA - TERMS OF AGREEMENT WITH CTT INCLUDE AN UPFRONT LICENSING FEE, CERTAIN MILESTONE AND ROYALTY PAYMENTS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-12T14:08:00.000+02:00", "crawled": "2018-02-12T14:24:39.008+02:00", "highlightTitle": ""}